Escalon Medical Corp.
ESMC
$0.2922
-$0.0015-0.51%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.19% | -1.74% | -5.61% | -1.63% | -2.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.19% | -1.74% | -5.61% | -1.63% | -2.60% |
| Cost of Revenue | 8.85% | 2.08% | -0.66% | 2.04% | 1.18% |
| Gross Profit | 14.15% | -6.17% | -11.50% | -6.11% | -7.00% |
| SG&A Expenses | 2.31% | 5.61% | 9.23% | 9.04% | 3.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.32% | 2.42% | 1.64% | 3.28% | 0.49% |
| Operating Income | 1,801.59% | -70.27% | -114.87% | -121.81% | -111.49% |
| Income Before Tax | 1,112.58% | -72.88% | -118.01% | -127.40% | -119.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1,112.58% | -72.88% | -118.01% | -127.40% | -119.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,112.58% | -72.88% | -118.01% | -127.40% | -119.84% |
| EBIT | 1,801.59% | -70.27% | -114.87% | -121.81% | -111.49% |
| EBITDA | 230,733.33% | -66.29% | -108.51% | -111.15% | -100.08% |
| EPS Basic | 213.00% | -94.57% | -136.04% | -179.87% | -215.27% |
| Normalized Basic EPS | 1,103.85% | -73.01% | -118.05% | -127.53% | -120.00% |
| EPS Diluted | 203.25% | -102.30% | -182.25% | -140.40% | -700.00% |
| Normalized Diluted EPS | 344.19% | -79.21% | -134.02% | -223.26% | -439.47% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 19.44% | -13.77% | -29.60% | -29.60% | 0.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |